JP2005512509A5 - - Google Patents

Download PDF

Info

Publication number
JP2005512509A5
JP2005512509A5 JP2002589708A JP2002589708A JP2005512509A5 JP 2005512509 A5 JP2005512509 A5 JP 2005512509A5 JP 2002589708 A JP2002589708 A JP 2002589708A JP 2002589708 A JP2002589708 A JP 2002589708A JP 2005512509 A5 JP2005512509 A5 JP 2005512509A5
Authority
JP
Japan
Prior art keywords
composition
protein
polynucleotide
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002589708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005512509A (ja
Filing date
Publication date
Priority claimed from US10/001,469 external-priority patent/US7208280B2/en
Priority claimed from US10/017,066 external-priority patent/US6838258B2/en
Application filed filed Critical
Priority claimed from PCT/US2002/015520 external-priority patent/WO2002092842A2/en
Publication of JP2005512509A publication Critical patent/JP2005512509A/ja
Publication of JP2005512509A5 publication Critical patent/JP2005512509A5/ja
Pending legal-status Critical Current

Links

JP2002589708A 2001-05-15 2002-05-15 癌の処置および検出において有用な１０１ｐ３ａ１１またはｐｈｏｒ−１と名称が与えられる核酸および対応するタンパク質 Pending JP2005512509A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29111801P 2001-05-15 2001-05-15
US10/001,469 US7208280B2 (en) 1999-10-05 2001-10-31 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US10/017,066 US6838258B2 (en) 1999-10-05 2001-12-14 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
PCT/US2002/015520 WO2002092842A2 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer

Publications (2)

Publication Number Publication Date
JP2005512509A JP2005512509A (ja) 2005-05-12
JP2005512509A5 true JP2005512509A5 (enExample) 2005-12-22

Family

ID=38616826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589708A Pending JP2005512509A (ja) 2001-05-15 2002-05-15 癌の処置および検出において有用な１０１ｐ３ａ１１またはｐｈｏｒ−１と名称が与えられる核酸および対応するタンパク質

Country Status (6)

Country Link
EP (1) EP1539805A4 (enExample)
JP (1) JP2005512509A (enExample)
AU (2) AU2002309873B2 (enExample)
CA (1) CA2447564A1 (enExample)
IL (1) IL158860A0 (enExample)
WO (1) WO2002092842A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
WO2004078928A2 (en) * 2003-02-28 2004-09-16 The Johns Hopkins University T cell regulation
JP5122592B2 (ja) * 2010-01-04 2013-01-16 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
US10722563B2 (en) * 2012-09-20 2020-07-28 Shenzhen Innovation Immunotechnology Co., Ltd. Prostate-specific tumor antigens and uses thereof
CN111549140B (zh) * 2020-06-08 2023-08-08 重庆医科大学附属第一医院 一种检测肺癌相关基因C2orf40、FIBIN和GRP甲基化的试剂盒及其应用
CN119920083B (zh) * 2025-01-21 2025-10-31 重庆邮电大学 一种通信中断条件下基于事件触发的混行车群切换协同控制方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914142B9 (en) * 1996-03-11 2012-01-04 Epimmune Inc. Peptides with increased binding affinity for at least three hla-a3-like molecules
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
WO2000044775A2 (en) * 1999-01-27 2000-08-03 Epimmune Inc. Identification of broadly reactive hla restricted t cell epitopes
JP4272376B2 (ja) * 1999-10-05 2009-06-03 アジェンシス，インコーポレイテッド 前立腺ガンにおいてアップレギュレートされるｇタンパク質結合レセプターおよびその使用
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
WO2001027158A2 (en) * 1999-10-08 2001-04-19 Digiscents Olfactory receptor sequences
JP2004504010A (ja) * 2000-03-13 2004-02-12 セノミックス　インコーポレイテッド ヒト嗅覚レセプター及びそれをコードする遺伝子
JP2004504808A (ja) * 2000-03-27 2004-02-19 コリクサ　コーポレイション 前立腺癌の治療及び診断のための組成物及び方法
CA2404541A1 (en) * 2000-03-31 2001-10-11 Curagen Corporation G-protein coupled receptors and nucleic acids encoding same
US20030022237A1 (en) * 2000-09-27 2003-01-30 Feder John N. Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Similar Documents

Publication Publication Date Title
JP2005505271A5 (enExample)
US11358995B2 (en) Compositions and methods of use for treating metabolic disorders
JP2006513724A5 (enExample)
US10869909B2 (en) Compositions and methods of use for treating metabolic disorders
US6777388B1 (en) Leptin-related peptides
TWI356062B (en) Therapeutic peptides and method
JP2008194039A (ja) 新規線維芽細胞増殖因子（ｆｇｆ２３）および使用方法
JP2002521055A (ja) ９８個のヒト分泌タンパク質
HU227703B1 (en) Mammalian cytokine-like polypeptide-10
JP2018535964A (ja) 線維芽細胞増殖因子（ｆｇｆ）１アナログによるステロイド誘導性高血糖の処置
JP2001512667A (ja) ヒトオーファンレセプターｎｔｒ−１
KR100375260B1 (ko) 글루카곤수용체
JP2011200233A5 (enExample)
JP2005512509A5 (enExample)
CA3180251A1 (en) Cytokine conjugates
TWI238191B (en) IL-17 like molecules and uses thereof
US11560412B2 (en) Compositions comprising GRIM-19 therapeutics and methods of use
JP2005508157A5 (enExample)
EP1874331B1 (en) Use of bip against bone loss and osteoporosis
JP2002508170A (ja) 哺乳動物カルシトニン様ポリペプチド−１
HK1206260B (en) Compositions and methods of use for treating metabolic disorders
HK1237790B (en) Compositions and methods of use for treating metabolic disorders
BR112017001789B1 (pt) Polipeptídeos, dímero, método de produção dos mesmos, composição farmacêutica, uso dos mesmos e recipiente estéril para tratamento de distúrbios metabólicos
MXPA01007332A (en) Zsig67:a member of the human secretin-glucagon-vip hormone family